位置:首页 > 蛋白库 > MCE_MYXVU
MCE_MYXVU
ID   MCE_MYXVU               Reviewed;         338 AA.
AC   P68545; P18628;
DT   23-NOV-2004, integrated into UniProtKB/Swiss-Prot.
DT   23-NOV-2004, sequence version 1.
DT   03-AUG-2022, entry version 73.
DE   RecName: Full=Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase;
DE            EC=2.1.1.57;
DE   AltName: Full=Poly(A) polymerase regulatory subunit;
DE   AltName: Full=Poly(A) polymerase small subunit;
DE            Short=PAP-S;
DE   AltName: Full=VP39;
GN   Name=PAPS; ORFNames=F9;
OS   Myxoma virus (strain Uriarra) (MYXV).
OC   Viruses; Varidnaviria; Bamfordvirae; Nucleocytoviricota; Pokkesviricetes;
OC   Chitovirales; Poxviridae; Chordopoxvirinae; Leporipoxvirus.
OX   NCBI_TaxID=265876;
OH   NCBI_TaxID=9986; Oryctolagus cuniculus (Rabbit).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2402456; DOI=10.1093/nar/18.17.5290;
RA   Jackson R.J., Bults G.H.;
RT   "A myxoma virus nucleotide sequence with homology to the vaccinia virus RNA
RT   polymerase 22-kDa subunit gene.";
RL   Nucleic Acids Res. 18:5290-5290(1990).
CC   -!- FUNCTION: Displays methyltransferase, positive regulation of the
CC       poly(A) polymerase and transcription elongation activities. Involved in
CC       the modification of both mRNA ends and in intermediate and late gene
CC       positive transcription elongation. At the mRNAs 5' end, methylates the
CC       ribose 2' OH group of the first transcribed nucleotide, thereby
CC       producing a 2'-O-methylpurine cap. At the 3' end, functions as a
CC       processivity factor which stimulates the activity of the viral poly(A)
CC       polymerase VP55 that creates mRNA's poly(A) tail. In the presence of
CC       VP39, VP55 does not dissociate from the RNA allowing tail elongation to
CC       around 250 adenylates. {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 5'-end (N(7)-methyl 5'-triphosphoguanosine)-ribonucleoside
CC         in mRNA + S-adenosyl-L-methionine = a 5'-end (N(7)-methyl 5'-
CC         triphosphoguanosine)-(2'-O-methyl-ribonucleoside) in mRNA + H(+) + S-
CC         adenosyl-L-homocysteine; Xref=Rhea:RHEA:67020, Rhea:RHEA-COMP:17167,
CC         Rhea:RHEA-COMP:17168, ChEBI:CHEBI:15378, ChEBI:CHEBI:57856,
CC         ChEBI:CHEBI:59789, ChEBI:CHEBI:156461, ChEBI:CHEBI:167609;
CC         EC=2.1.1.57;
CC   -!- SUBUNIT: Methyltransferase activity: Monomer, poly(A) polymerase
CC       activity: Heterodimer composed of a catalytic component, VP55, and a
CC       processivity factor, VP39. Interacts with Rap94 and NPH-I; these
CC       interactions might help linking transcription to capping and
CC       polyadenylation. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Virion {ECO:0000305}. Note=Localizes to the
CC       virion core. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the class I-like SAM-binding methyltransferase
CC       superfamily. Poxvirus/kinetoplastid 2'-O-MTase family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00944}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X17347; CAA35229.1; -; Genomic_DNA.
DR   PIR; S11241; S11241.
DR   RefSeq; NP_051779.1; NC_001132.2.
DR   SMR; P68545; -.
DR   GeneID; 932114; -.
DR   KEGG; vg:932114; -.
DR   GO; GO:0004483; F:mRNA (nucleoside-2'-O-)-methyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0003746; F:translation elongation factor activity; IEA:UniProtKB-KW.
DR   GO; GO:0006370; P:7-methylguanosine mRNA capping; IEA:UniProtKB-KW.
DR   GO; GO:0031440; P:regulation of mRNA 3'-end processing; IEA:InterPro.
DR   CDD; cd20756; capping_2-OMTase_Poxviridae; 1.
DR   Gene3D; 3.40.50.150; -; 1.
DR   InterPro; IPR000176; mRNA_MeTrfase-like.
DR   InterPro; IPR025804; Pox/kineto_cap_MeTfrase.
DR   InterPro; IPR030375; Poxvir_cap_MeTfrase.
DR   InterPro; IPR029063; SAM-dependent_MTases_sf.
DR   Pfam; PF01358; PARP_regulatory; 1.
DR   PIRSF; PIRSF003726; PolA_polym_reg_poxV; 1.
DR   SUPFAM; SSF53335; SSF53335; 1.
DR   PROSITE; PS51612; SAM_MT_2O_PK; 1.
PE   3: Inferred from homology;
KW   Elongation factor; Methyltransferase; mRNA capping; mRNA processing;
KW   Protein biosynthesis; S-adenosyl-L-methionine; Transcription; Transferase;
KW   Virion.
FT   CHAIN           1..338
FT                   /note="Cap-specific mRNA (nucleoside-2'-O-)-
FT                   methyltransferase"
FT                   /id="PRO_0000099117"
FT   REGION          169..333
FT                   /note="Binding to Rap94"
FT                   /evidence="ECO:0000250"
FT   REGION          169..249
FT                   /note="Binding to NPH-I"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00944"
FT   REGION          305..338
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        175
FT                   /note="For methyltransferase activity"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00944"
FT   BINDING         22
FT                   /ligand="mRNA"
FT                   /ligand_id="ChEBI:CHEBI:33699"
FT                   /ligand_part="mRNA cap"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00944"
FT   BINDING         39
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00944"
FT   BINDING         66
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00944"
FT   BINDING         68
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00944"
FT   BINDING         72
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00944"
FT   BINDING         95
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00944"
FT   BINDING         97
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00944"
FT   BINDING         116
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00944"
FT   BINDING         138
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00944"
FT   BINDING         177..180
FT                   /ligand="mRNA"
FT                   /ligand_id="ChEBI:CHEBI:33699"
FT                   /ligand_part="mRNA cap"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00944"
FT   BINDING         182
FT                   /ligand="mRNA"
FT                   /ligand_id="ChEBI:CHEBI:33699"
FT                   /ligand_part="mRNA cap"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00944"
FT   BINDING         205..207
FT                   /ligand="mRNA"
FT                   /ligand_id="ChEBI:CHEBI:33699"
FT                   /ligand_part="mRNA cap"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00944"
FT   BINDING         233
FT                   /ligand="mRNA"
FT                   /ligand_id="ChEBI:CHEBI:33699"
FT                   /ligand_part="mRNA cap"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00944"
SQ   SEQUENCE   338 AA;  39722 MW;  F57436067FD239CB CRC64;
     MEPVSMDKPF MYFDEIDDEL EYEPESVNET PKKLPHQGQL KLLLGELFFL SKLQRHGILD
     GSTIVYIGSA PGTHIKYLRD HFMSMGLVIK WMLIDGRTHD PILEGLRDVI LITKFVDEAY
     IRQLKKQLYP SRVILISDVR SKRGQKEPTT QDLLSNYSLQ NIMVSVLKPA ASSLKWRCPF
     PDQWIKDFYV PHGNEMLQPF APSYSAEMRL LSIYSGTPIR LKCITQQDSS KYEKKMYYLN
     KIIRNRIIIN FDYSNQEYDF FHMYHMLKTV YSNKSFTSNK SKVLHFHQSI FRFLKIPITN
     TEKIHHEPTQ RKVPSKNTML KSRNTKKSVR GNKQGRRT
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024